Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Defining the role of recombinant activated factor VII in pediatric cardiac surgery: Where should we go from here?*

1 Sept 2009

Abstract excerpt

OBJECTIVES: Postoperative hemorrhage is a recognized complication of pediatric cardiac surgery. Both the immature coagulation system and increased susceptibility to hemodilution increase the likelihood of pediatric patients developing coagulopathy when compared with adult counterparts. Treatment options remain limited. Recombinant factor VII (rFVIIa) is a hemostatic agent increasingly used to reduce hemorrhage in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Hemophilia Treatment and Research

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 19451849
DOI: 10.1097/pcc.0b013e3181a642d5

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Defining the role of recombinant activated factor VII in pediatric cardiac surgery: Where should we go from here?*PMID 19451849Read ↗

Ten‐year experience of recombinant activated factor VII use in surgical patients with congenital haemophilia with inhibitors or acquired haemophilia in JapanSemantic proximity Read ↗

Analysis of prothrombotic mutations and polymorphisms in children who developed thrombosis in the perioperative period of congenital cardiac surgery.Semantic proximity Read ↗

Efficacy and safety of Wilate in paediatric VWD patients under 6 years of age - results of a prospective multicentre clinical study including recovery information.Semantic proximity Read ↗

Effect of 22q11.2 deletion on bleeding and transfusion utilization in children with congenital heart disease undergoing cardiac surgery.Semantic proximity Read ↗

Novel perspectives on diagnosis and clinical significance of the post-thrombotic syndrome in children.Semantic proximity Read ↗

Value of preoperative risk adjustment in congenital heart surgery (RACHS) score versus the vasoactive-ventilation-renal (VVR) score for predicting postoperative outcomes in neonates and childrenSemantic proximity Read ↗

Safety and effectiveness of recombinant factor XIII‐A2 in congenital factor XIII deficiency: Real‐world evidenceSemantic proximity Read ↗

Neutrophil extracellular traps formation is associated with postoperative complications in neonates and infants undergoing congenital cardiac surgerySemantic proximity Read ↗

Immediate postnatal cardiac surgery versus conventional neonatal cardiac surgery for critical congenital heart disease: a propensity score-matched cohort studySemantic proximity Read ↗

Factors influencing neurologic outcome after neonatal cardiopulmonary bypass: what we can and cannot control.Semantic proximity Read ↗

Premedication of Pediatric Cardiac Population with Midazolam: Comparison of Oral Versus Sublingual Route of Administration in Terms of Effectiveness and Possible Side Effects. Evaluation of Pharmacokinetic, Haemodynamic and Behavioral OutcomesSemantic proximity Read ↗

Periventricular leukomalacia is common after neonatal cardiac surgery.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.